Dupilumab, cendakimab, and a budesonide formulation were linked to symptomatic improvement in eosinophilic esophagitis, in a meta-analysis of 13 randomized controlled trials.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/top-three-treatments-dysphagia-relief-eosinophilic-2026a1000hs2?src=rss
Author :
Publish date : 2026-05-28 09:18:00
Copyright for syndicated content belongs to the linked Source.
